Literature DB >> 1459277

The role of office hysteroscopy in in vitro fertilization.

F N Shamma1, G Lee, J N Gutmann, G Lavy.   

Abstract

Twenty-eight patients participated prospectively in a study to evaluate the impact of hysteroscopically detected uterine and cervical anomalies on the success rate of ET in an IVF-ET program. All participants had a normal intrauterine cavity by standard HSG. All the patients had a diagnostic office hysteroscopy under paracervical block before commencing COH. Because our IVF program does not include hysteroscopy as a requirement before undergoing IVF and because the significance of mild intrauterine abnormalities is not yet known, the hysteroscopic findings were not relayed to the personnel involved in the IVF-ET procedure. Sixteen patients (group I) had a normal hysteroscopic evaluation. Twelve patients (group II) had abnormal hysteroscopic findings including small uterine septa, small submucous fibroids, uterine hypoplasia and cervical ridges. Although no difference in patients or cycle characteristics was present, there was a significant difference in the clinical PR between patients in groups I and II. In conclusion, in an IVF-ET program patients with normal hysterography but abnormal hysteroscopic findings had a significantly lower clinical PR, demonstrating the importance of performing hysteroscopy before IVF-ET.

Entities:  

Mesh:

Year:  1992        PMID: 1459277

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  9 in total

1.  What is a preclinical pregnancy loss?

Authors:  C B Coulam; C Chapman; J S Rinehart
Journal:  J Assist Reprod Genet       Date:  1998-04       Impact factor: 3.412

2.  The effect of endometrial polyps on outcomes of in vitro fertilization (IVF) cycles.

Authors:  A Lass; G Williams; N Abusheikha; P Brinsden
Journal:  J Assist Reprod Genet       Date:  1999-09       Impact factor: 3.412

3.  The inSIGHT study: costs and effects of routine hysteroscopy prior to a first IVF treatment cycle. A randomised controlled trial.

Authors:  Janine G Smit; Jenneke C Kasius; Marinus J C Eijkemans; Carolien A M Koks; Ron Van Golde; Jurjen G E Oosterhuis; Annemiek W Nap; Gabrielle J Scheffer; Petra A P Manger; Annemiek Hoek; Mesrure Kaplan; Dick B C Schoot; Arne M van Heusden; Walter K H Kuchenbecker; Denise A M Perquin; Kathrin Fleischer; Eugenie M Kaaijk; Alexander Sluijmer; Jaap Friederich; Joop S E Laven; Marcel van Hooff; Leonie A Louwe; Janet Kwee; Jantien J Boomgaard; Corry H de Koning; Ineke C A H Janssen; Femke Mol; Ben W J Mol; Helen L Torrance; Frank J M Broekmans
Journal:  BMC Womens Health       Date:  2012-08-08       Impact factor: 2.809

Review 4.  The prevalence of congenital uterine anomalies in unselected and high-risk populations: a systematic review.

Authors:  Y Y Chan; K Jayaprakasan; J Zamora; J G Thornton; N Raine-Fenning; A Coomarasamy
Journal:  Hum Reprod Update       Date:  2011-06-24       Impact factor: 15.610

5.  Hysteroscopic findings in patients with a history of two implantation failures following in vitro fertilization.

Authors:  Ashraf Moini; Kiandokht Kiani; Firouzeh Ghaffari; Fatemeh Hosseini
Journal:  Int J Fertil Steril       Date:  2012-06-19

Review 6.  Approaches to improve the diagnosis and management of infertility.

Authors:  P Devroey; B C J M Fauser; K Diedrich
Journal:  Hum Reprod Update       Date:  2009-04-20       Impact factor: 15.610

7.  A multi-centre randomised controlled study of pre-IVF outpatient hysteroscopy in women with recurrent IVF implantation failure: Trial of Outpatient Hysteroscopy - [TROPHY] in IVF.

Authors:  Tarek El-Toukhy; Rudi Campo; Sesh Kamal Sunkara; Yacoub Khalaf; Arri Coomarasamy
Journal:  Reprod Health       Date:  2009-12-03       Impact factor: 3.223

8.  1000 office-based hysteroscopies prior to in vitro fertilization: feasibility and findings.

Authors:  Mary D Hinckley; Amin A Milki
Journal:  JSLS       Date:  2004 Apr-Jun       Impact factor: 2.172

Review 9.  Diagnostic and therapeutic options in recurrent implantation failure.

Authors:  Sarah Moustafa; Steven L Young
Journal:  F1000Res       Date:  2020-03-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.